# Obsidian Therapeutics

**Canonical:** https://apis.io/providers/obsidian-therapeutics/  
**Website:** https://obsidiantx.com  
**APIs profiled:** 0

Obsidian Therapeutics is a clinical-stage biotechnology company developing engineered cell and gene therapies built on its proprietary cytoDRiVE platform, which uses drug-responsive domains to regulate therapeutic protein function with an FDA-approved small molecule. Its lead program, OBX-115, is in Phase 2 trials for advanced melanoma. The company was surfaced as a portfolio company of GV and added to the API Evangelist network. It is a life-sciences company with no public developer or API surface.

## Kin Score — 9.1 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 9.1).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 6.0 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 10.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Life Sciences, Biotechnology, Cell and Gene Therapy, Pharmaceuticals, Precision Medicine, Oncology

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/obsidian-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.